BlackRock Fund Advisors’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6.49M Buy
1,311,508
+169,524
+15% +$768K ﹤0.01% 2805
2016
Q3
$4.75M Buy
1,141,984
+86,587
+8% +$354K ﹤0.01% 2866
2016
Q2
$4.18M Buy
1,055,397
+247,845
+31% +$972K ﹤0.01% 2902
2016
Q1
$2.69M Sell
807,552
-43,811
-5% -$144K ﹤0.01% 2992
2015
Q4
$3.63M Buy
851,363
+29,347
+4% +$126K ﹤0.01% 2987
2015
Q3
$3.45M Buy
822,016
+12,327
+2% +$77.7K ﹤0.01% 2971
2015
Q2
$6.59M Buy
809,689
+466,813
+136% +$3.89M ﹤0.01% 2755
2015
Q1
$2.66M Buy
342,876
+3,527
+1% +$30.2K ﹤0.01% 3076
2014
Q4
$3.97M Buy
339,349
+62,372
+23% +$744K ﹤0.01% 2991
2014
Q3
$3.58M Sell
276,977
-11,452
-4% -$151K ﹤0.01% 2938
2014
Q2
$4.38M Buy
+288,429
New +$4.69M ﹤0.01% 2909

Other funds holding CSLT

BlackRock Fund Advisors's CSLT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its CASTLIGHT HEALTH, INC. (CSLT) stake by 15% in Q4 2016, buying an estimated $768K and bringing the position to 1,311,508 shares worth $6.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2805.

BlackRock Fund Advisors first reported a position in CSLT in Q2 2014 and has held it in 11 quarters since. The position peaked at $6.59M in Q2 2015. 103 funds tracked by Wall St. Rank hold CSLT as of Q4 2016.

  • BlackRock Fund Advisors held 1,311,508 shares of CASTLIGHT HEALTH, INC. worth $6.49M as of Q4 2016.
  • BlackRock Fund Advisors bought 169,524 CASTLIGHT HEALTH, INC. shares in Q4 2016, an estimated $768K.
  • CASTLIGHT HEALTH, INC. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2805 holding.
  • BlackRock Fund Advisors first reported a position in CASTLIGHT HEALTH, INC. in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Fund Advisors's CASTLIGHT HEALTH, INC. position peaked at $6.59M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.